Empagliflozin and uric acid metabolism in diabetes: A post hoc analysis of the EMPA-REG OUTCOME trial,Diabetes, Obesity and Metabolism

当前位置： X-MOL 学术 › Diabetes Obes. Metab. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Empagliflozin and uric acid metabolism in diabetes: A post hoc analysis of the EMPA-REG OUTCOME trial
Diabetes, Obesity and Metabolism ( IF 5.4 ) Pub Date : 2021-09-24 , DOI: 10.1111/dom.14559
João Pedro Ferreira _{1,

2} , Silvio E. Inzucchi ₃ , Michaela Mattheus ₄ , Thomas Meinicke ₄ , Dominik Steubl _{4,

5} , Christoph Wanner ₆ , Bernard Zinman ₇

Affiliation

To evaluate the effect of empagliflozin on uric acid (UA) levels, antigout medication and gout episodes in the EMPA-REG OUTCOME trial (NCT01131676).

中文翻译：